Exodus Point Capital Management, LP Cure Vac N.V. Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
A detailed history of Exodus Point Capital Management, LP transactions in Cure Vac N.V. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 24,356 shares of CVAC stock, worth $73,798. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,356
Previous 255,164
90.45%
Holding current value
$73,798
Previous $773,000
89.26%
% of portfolio
0.0%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding CVAC
# of Institutions
99Shares Held
14.4MCall Options Held
241KPut Options Held
419K-
Israel Englander Millennium Management LLC | New York, Ny2.87MShares$8.7 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.42MShares$7.34 Million0.02% of portfolio
-
Black Rock Inc. New York, NY2.25MShares$6.83 Million0.0% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.6MShares$4.84 Million9.09% of portfolio
-
Camber Capital Management LP Boston, MA550KShares$1.67 Million0.05% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $568M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...